Robotic-Assisted Spine Surgery for Spinal Conditions
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a robotic system called Mazor X, which assists doctors in placing screws more accurately in the spine during surgery. It targets individuals with spine issues, such as degenerative conditions or injuries between the T2 and S1 vertebrae. The trial aims to determine if the robot can guide the screws to the intended location. It is suitable for those requiring spinal surgery at The Ohio State University Wexner Medical Center for specific spine problems. As an unphased trial, it offers patients the chance to contribute to innovative surgical advancements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What prior data suggests that the Mazor X robotic system is safe for spinal surgery?
Research shows that robotic systems, such as the Mazor X Robotic System, hold promise for spine surgeries by helping to place screws precisely, a crucial aspect of these procedures. Studies comparing robotic systems indicate they improve accuracy and surgical outcomes, reducing mistakes during surgery.
However, some reports have noted complications. Specifically, after using the Mazor X system, six patients experienced wound issues within 90 days and required additional surgery to address these problems.
Overall, robotic systems in spinal surgery appear safe but carry some risks. They enhance surgical accuracy, but patients should be aware of potential complications. Patients should consult their doctor to understand the risks and benefits.12345Why are researchers excited about this trial?
The Mazor X Robotic System is unique because it brings a high level of precision and planning to spine surgery, which traditional methods can't match. Unlike standard surgical techniques, which rely heavily on the surgeon's skill and experience, this system allows for detailed preoperative planning and real-time guidance during surgery. Researchers are excited about this technology because it can potentially reduce complications, improve surgical outcomes, and shorten recovery times by enhancing accuracy and consistency in spinal procedures.
What evidence suggests that the Mazor X robotic system is effective for spinal conditions?
Research has shown that the Mazor X Robotic System enhances the accuracy of spinal surgeries by improving screw placement in the spine. Studies have found that this system reduces the likelihood of errors, which can occur up to 16.9% of the time with manual screw placement, particularly in challenging areas like the upper neck. Robotic assistance generally makes these surgeries safer and more precise. In this trial, all participants will undergo procedures using the Mazor X system, which is highly regarded in the medical community for reducing errors and improving surgical outcomes. Its capability to meticulously plan and execute surgeries makes it a promising tool for treating spinal issues.12367
Are You a Good Fit for This Trial?
This trial is for adults over 18 with conditions like scoliosis, spinal infections, trauma, cancer, or degenerative issues in the spine needing screws placed between T2-S1 vertebrae. Surgery must be done at The Ohio State University Wexner Medical Center by a study investigator.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo posterior thoracolumbar arthrodesis procedures using the Mazor X robotic system
Follow-up
Participants are monitored for screw deviation and accuracy assessment post-surgery
Study Completion
Final assessment of screw deviation and accuracy
What Are the Treatments Tested in This Trial?
Interventions
- Mazor X Robotic System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Medtronic
Industry Sponsor
Geoff Martha
Medtronic
Chief Executive Officer since 2020
Finance degree from Penn State University
Dr. Richard Kuntz
Medtronic
Chief Medical Officer since 2023
MD, MSc